back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-03-22 Tx date 2014-09-15 |
$VP
Vodis Pharmaceuticals Inc. |
Boulton, L. Clive B.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2014-09-30 |
$VP
Vodis Pharmaceuticals Inc. |
Boulton, L. Clive B.
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$12,000
+30,000 vol $0.40 each |
30,000 | |
| Filed 2016-03-22 Tx date 2015-03-31 |
$VP
Vodis Pharmaceuticals Inc. |
Boulton, L. Clive B.
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+100,000 vol $0.10 each |
130,000 | |
| Filed 2016-03-22 Tx date 2014-09-15 |
$VP
Vodis Pharmaceuticals Inc. |
Boulton, L. Clive B.
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2014-09-30 |
$VP
Vodis Pharmaceuticals Inc. |
Boulton, L. Clive B.
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+15,000 vol |
15,000 | |
| Filed 2016-03-08 Tx date 2016-01-06 |
$VP
Vodis Pharmaceuticals Inc. |
Boulton, L. Clive B.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
450,000 |